Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Alitretinoin 30mg capsules	TA177 - Alitretinoin for the treatment of severe chronic hand eczema
Alprostadil (Prostin VR)
Alteplase injection	TA52 - Guidance on the use of drugs for early thrombolysis in the treatment of acute myocardial infarction	Hospital use only
Aminophylline injection (Phyllocontin Continus®)		Hospital use only
Amiodarone injection		Hospital only
Amoxicillin nebulised		Hospital only
Amphotericin (Fungizone)		Hospital only
Amphotericin + Flucytosine in KY jelly
Anagrelide capsules
Anakinra (Kineret®)	TA685 - Anakinra for treating Still’s disease

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.